INFORMATION
-
-
- 09/11/2019
- PRESS RELEASE
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2020 (IFRS)
-
- 09/05/2019
- PRESS RELEASE
- Sagent Pharmaceuticals Announces FDA Acceptance of Omega Manufacturing Site
-
- 06/03/2019
- PRESS RELEASE
- Notice of the 55th Ordinary General Meeting of Shareholders
-
- 05/13/2019
- PRESS RELEASE
- The 8th Mid-term Business Plan
-
